Evidence map›Paper›PMID 32905653›Full record

ArticleAmerican journal of reproductive immunology (New York, N.Y. : 1989)2021

Circulating CD14

Ashley E Stenzel, Scott I Abrams, Janine M Joseph, Ellen L Goode, Joseph D Tario, Paul K Wallace, Divjot Kaur, Anna-Kay Adamson, Matthew F Buas, Amit A Lugade and 12 more

Open access · greenAbstract read
In one paragraph

Article in American journal of reproductive immunology (New York, N.Y. : 1989), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.2field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Heterogeneity of monocytes in cancer.American journal of cancer research · 2025
    Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Monocyte programming by cancer therapy.Frontiers in immunology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 4 institutions in 1 country.

Ashley E StenzelDepartment of Cancer Prevention and Control, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
Scott I AbramsDepartment of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
Janine M JosephDepartment of Cancer Prevention and Control, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
Ellen L GoodeDivision of Epidemiology, Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
Joseph D TarioDepartment of Flow & Image Cytometry, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
Paul K WallaceDepartment of Flow & Image Cytometry, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
Divjot KaurDepartment of Cancer Prevention and Control, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
Anna-Kay AdamsonDepartment of Cancer Prevention and Control, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
Matthew F BuasDepartment of Cancer Prevention and Control, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
Amit A LugadeCenter for Immunotherapy, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
Angela LaslavicDepartment of Obstetrics, Gynecology & Reproductive Sciences, University of Pittsburgh and Hillman Cancer Center, Pittsburgh, PA, USA.
Sarah E TaylorDepartment of Obstetrics, Gynecology & Reproductive Sciences, University of Pittsburgh and Hillman Cancer Center, Pittsburgh, PA, USA.
Brian OrrDepartment of Obstetrics, Gynecology & Reproductive Sciences, University of Pittsburgh and Hillman Cancer Center, Pittsburgh, PA, USA.
Robert P EdwardsDepartment of Obstetrics, Gynecology & Reproductive Sciences, University of Pittsburgh and Hillman Cancer Center, Pittsburgh, PA, USA.
Esther ElishaevDepartment of Pathology, University of Pittsburgh and Hillman Cancer Center, Pittsburgh, PA, USA.
Kunle OdunsiDepartment of Gynecologic Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
Jennifer M MongioviDepartment of Cancer Prevention and Control, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
John Lewis EtterDepartment of Cancer Prevention and Control, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
Stacey J WinhamDivision of Epidemiology, Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
Scott H KaufmannDivision of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, MN, USA.
Francesmary ModugnoDepartment of Obstetrics, Gynecology & Reproductive Sciences, University of Pittsburgh and Hillman Cancer Center, Pittsburgh, PA, USA.
Kirsten B MoysichDepartment of Cancer Prevention and Control, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.ORCID 0000-0002-4678-2058
Roswell Park Comprehensive Cancer Center · USUPMC Hillman Cancer Center · USMayo Clinic in Florida · USMayo Clinic · US

Funding

VECTOR CORE FACILITYP30CA047904 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Jessie Nedrow · 1988 to 2026
$158.0M
Use of microfluidic tumor cultures to enable clinical trials of therapies for ovarian cancerP50CA136393 · NCI · MAYO CLINIC ROCHESTER · PI Zhenkun Lou · 2009 to 2026
$37.0M
RPCI-UPCI Ovarian Cancer SPOREP50CA159981 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI MOYSICH, KIRSTEN B. · 2013 to 2025
$19.6M
Relating Molecular Subgroups of Endometriosis-Associated Ovarian Cancers to Survival and RiskR01CA248288 · NCI · MAYO CLINIC ROCHESTER · PI Stacey J Winham · 2021 to 2026
$4.8M
Interdisciplinary Training in Cancer Epidemiology at UBT32CA113951 · NCI · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI FREUDENHEIM, JO L., MOYSICH, KIRSTEN B. · 2017 to 2021
$693k
NCI NIH HHS P30 CA047904NCI NIH HHS P50 CA136393NCI NIH HHS P50 CA159981NCI NIH HHS R01 CA248288NCI NIH HHS T32 CA113951
6 · The paper itself

Abstract

problemPrevious studies identified circulating CD14 METHOD OF STUDY: Incident cases of 236 women with EOC were recruited and comprehensive flow cytometry was utilized to assess the frequency of peripheral blood CD33

resultsPatients with elevated frequencies of circulating CD14

conclusionThese findings support the potential clinical relevance of CD14

Indexed as

AgedBiomarkersCarcinogenesisDisease ProgressionEpithelial CellsFemaleHLA-DR AntigensHumansImidesImmune ToleranceLipopolysaccharide ReceptorsMiddle AgedNeoplasm StagingOvarian NeoplasmsPolyphosphatesPrognosisBiomarkersHLA-DR AntigensImidesLipopolysaccharide Receptorsmonoimido-cyclo-triphosphatePolyphosphatesbiomarkerMDSCmonocytesmonocytic cellsovarian cancer

Identifiers

PMID32905653
PMCPMC7897210
OpenAlexW3084810471

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.